Diabetic Medicine special issue highlights the work of the PSAD in understanding the psychosocial experience of living with diabetes
Category: hypoglycaemia
The latest in diabetes technologies and treatments
Highlights from the ATTD and a summary of the research presented by the ACBRD
By Jasmine Schipp and Shaira Baptista
Satisfaction with insulin delivery and glucose monitoring technologies in adults with long-standing type 1 diabetes and recurrent severe hypoglycaemia
Secondary analysis of the HypoCOMPaSS trial highlights greater satisfaction with insulin pump than multiple daily injections
The thoughts associated with awareness of hypoglycaemia and recurrent severe hypoglycaemia
Researchers from King’s College London have explored the role of beliefs about low and high glucose levels in ~2000 adults with type 1 diabetes
Severe hypoglycaemia: how does it impact people with type 2 diabetes?
The centre published the first systematic review on the psychological impact of severe hypoglycaemia in adults with type 2 diabetes
Celebrating DARP grant success for the ACBRD
Jennifer Halliday and colleagues have been awarded funding to investigate the feasibility of routine assessment of emotional health in type 1 diabetes centres
Mindful parenting is related to parental fear of hypoglycaemia
As World Diabetes Day places a focus on ‘the family and diabetes’, we share findings from our research with families of children with type 1 diabetes
Prevalence, awareness and self-monitoring of severe hypoglycemia: Results from the Diabetes MILES-Australia study
An ACBRD publication using the Diabetes MILES – Australia dataset looks into awareness of hypoglycaemia among adults with type 1 diabetes
HypoCOMPaSS study demonstrates 20-fold reduction in severe hypoglycaemia is sustained over 2 years following brief psycho-educational intervention and 6 months intensive clinical support
Prof Jane Speight’s collaboration with UK researchers has been published in Diabetes Care
HypoRESOLVE: rethinking the focus in diabetes
Prof Jane Speight joins team of 23 international experts for a major new European study into one of the most common and serious complications of diabetes – hypoglycaemia.